Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Uncover practical ways to stick to a budget tailored for young adults. Stay committed and watch your savings grow!
10,774 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Duquesne Family Office revealed positions in three AI infrastructure semiconductor firms, signaling a thematic bet on...
CrowdStrike is preparing a 4-for-1 stock split. This guide breaks down what that means for investors, how it affects ...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
As the CLARITY Act advances, these crypto tokens could see renewed investor interest. Grayscale highlights revenue-ge...
A 71-year-old retired teacher faces higher Medicare costs after benefits were restored under the Social Security Fair...
Chevron remains a heavyweight in energy stocks with a solid dividend, but recent volatility asks for a smarter plan. ...
SPHY has delivered monthly income since 2012, but 2026 tests whether its high-yield payout can withstand cyclical str...
A fleet driver allegedly ran up six figures on a single fuel card, highlighting how fuel-card programs can be misused...
Want one growth stock july hold that could power a lifetime of gains? This article lays out a proven framework and ex...
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...